参考文献/References:
[1] American Diabetes Association.10.Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2018[J].Diabetes Care,2018,41(Suppl 1):S105-S118.DOI:10.2337/dc18-S010.
[2] Zhang L,Long J,Jiang W,et al.Trends in chronic kidney disease in China[J].N Engl J Med,2016,375(9):905-906.DOI:10.1056/NEJMc1602469.
[3] 中华医学会内分泌学分会.成人甲状腺功能减退症诊治指南[J].中华内分泌代谢杂志, 2017, 33(2):167-180.DOI:10.3760/cma.j.issn.1000-6699.2017.02.018.
[4] 田勍,刘国强,洪天配.亚临床甲状腺功能异常与心血管疾病的关系[J].国际内分泌代谢杂志,2010,30(z1):15-18.DOI:10.3760/cma.j.issn.1673-4157.2010.s1.006.
[5] Han C,He X,Xia X,et al.Subclinical hypothyroidism and type 2 diabetes: a systematic review and meta-analysis[J].PLoS One,2015,10(8):e0135233.DOI:10.1371/journal.pone.0135233.
[6] Díez JJ,Iglesias P.An analysis of the relative risk for hypothyroidism in patients with type 2 diabetes[J].Diabet Med,2012,29(12):1510-1514.DOI:10.1111/j.1464-5491.2012.03687.x.
[7] Biondi B,Kahaly GJ,Robertson RP.Thyroid dysfunction and diabetes mellitus: two closely associated disorders[J].Endocr Rev,2019,40(3):789-824.DOI:10.1210/er.2018-00163.
[8] Demers LM,Spencer CA.Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease[J].Clin Endocrinol(Oxf),2003,58(2):138-140.DOI:10.1046/j.1365-2265.2003.01681.x.
[9] Wartofsky L,Dickey RA.The evidence for a narrower thyrotropin reference range is compelling[J].J Clin Endocrinol Metab,2005,90(9):5483-5488.DOI:10.1210/jc.2005-0455.
[10] Qi Q,Zhang QM,Li CJ,et al.Association of thyroid-stimulating hormone levels with microvascular complications in type 2 diabetes patients[J].Med Sci Monit,2017,23:2715-2720.DOI:10.12659/msm.902006.
[11] Kim BY,Kim CH,Jung CH,et al.Association between subclinical hypothyroidism and severe diabetic retinopathy in Korean patients with type 2 diabetes[J].Endocr J,2011,58(12):1065-1070.DOI:10.1507/endocrj.ej11-0199.
[12] Zou J,Tian F,Zhang Y,et al.Association between thyroid hormone levels and diabetic kidney disease in euthyroid patients with type 2 diabetes[J].Sci Rep,2018,8(1):4728.DOI:10.1038/s41598-018-22904-7.
[13] Yasuda T,Kaneto H,Kuroda A,et al.Subclinical hypothyroidism is independently associated with albuminuria in people with type 2 diabetes[J].Diabetes Res Clin Pract,2011,94(3):e75-e77.DOI:10.1016/j.diabres.2011.08.019.
[14] Shin DH,Lee MJ,Lee HS,et al. Thyroid hormone replacement therapy attenuates the decline of renal function in chronic kidney disease patients with subclinical hypothyroidism[J].Thyroid,2013,23(6):654-661.DOI:10.1089/thy.2012.0475.
[15] Al Sayed A,Al Ali N,Bo Abbas Y,et al.Subclinical hypothyroidism is associated with early insulin resistance in Kuwaiti women[J].Endocr J,2006,53(5):653-657.DOI:10.1507/endocrj.k06-018.
[16] Gong N,Gao C,Chen X,et al.Adipokine expression and endothelial function in subclinical hypothyroidism rats[J].Endocr Connect,2018,7(4):X1.DOI:10.1530/EC-18-0007e.
[17] Cheserek MJ,Wu GR,Ntazinda A,et al.Association between thyroid hormones, lipids and oxidative stress markers in subclinical hypothyroidism[J].J Med Biochem,2015,34(3):323-331.DOI:10.2478/jomb-2014-0044.
[18] Türemen EE, ?etinarslan B,瘙塁ahin T,et al.Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis[J].Endocr J,2011,58(5):349-354.DOI:10.1507/endocrj.k10e-333.
[19] Turkmen K.Inflammation, oxidative stress, apoptosis, and autophagy in diabetes mellitus and diabetic kidney disease: the Four Horsemen of the Apocalypse[J].Int Urol Nephrol,2017,49(5):837-844.DOI:10.1007/s11255-016-1488-4.
[20] Bjornstad P,Maahs DM,Cherney DZ,et al.Insulin sensitivity is an important determinant of renal health in adolescents with type 2 diabetes[J].Diabetes Care,2014,37(11):3033-3039.DOI:10.2337/dc14-1331.
[21] Hsu CC,Chang HY,Huang MC,et al.Association between insulin resistance and development of microalbuminuria in type 2 diabetes:a prospective cohort study[J].Diabetes Care,2011,34(4):982-987.DOI:10.2337/dc10-1718.
[22] Parle JV,Franklyn JA,Cross KW,et al.Prevalence and follow-up of abnormal thyrotrophin(TSH)concentrations in the elderly in the United Kingdom[J].Clin Endocrinol(Oxf),1991,34(1):77-83.DOI:10.1111/j.1365-2265.1991.tb01739.x.
[23] Fallahi P,Ferrari SM,Elia G,et al. Myo-inositol in autoimmune thyroiditis, and hypothyroidism[J].Rev Endocr Metab Disord,2018,19(4):349-354.DOI:10.1007/s11154-018-9477-9.
[24] Suher M,Koc E,Ata N,et al.Relation of thyroid disfunction, thyroid autoantibodies, and renal function[J].Ren Fail,2005,27(6):739-742.DOI:10.1080/08860220500243338.
[25] 任惠珠,王珊珊,郑妙艳,等.肾小球基底膜中胶原的合成、降解与糖尿病肾病[J].国际内分泌代谢杂志,2015,35(4):252-254.DOI:10.3760/cma.j.issn.1673-4157.2015.04.010.
相似文献/References:
[1]孙敏讷,段宇.老年亚临床甲状腺功能减退症的诊治特点[J].国际内分泌代谢杂志,2014,(06):411.[doi:10.3760/cma.j.issn.1673-4157.2014.06.014]
Sun Minne,Duan Yu..Diagnositc and therapeutic characteristics of subclinical hypothyroidism in elderly people[J].International Journal of Endocrinology and Metabolism,2014,(06):411.[doi:10.3760/cma.j.issn.1673-4157.2014.06.014]
[2]张建萍,孟召伟,谭建,等.甲状腺静态显像诊断双异位甲状腺的6年回顾性研究[J].国际内分泌代谢杂志,2015,(03):166.[doi:10.3760/cma.j.issn.1673-4157.2015.03.006]
Zhang Jianping*,Meng Zhaowei,Tan Jian,et al.Scintigraphic detection of dual ectopic thyroid: a six-year retrospective study[J].International Journal of Endocrinology and Metabolism,2015,(06):166.[doi:10.3760/cma.j.issn.1673-4157.2015.03.006]
[3]尹飞,李菲,李志红.亚临床甲状腺功能异常与骨质疏松[J].国际内分泌代谢杂志,2015,(04):258.[doi:10.3760/cma.j.issn.1673-4157.2015.04.012]
Yin Fei,Li Fei,Li Zhihong..Subclinical thyroid dysfunction and osteoporosis[J].International Journal of Endocrinology and Metabolism,2015,(06):258.[doi:10.3760/cma.j.issn.1673-4157.2015.04.012]
[4]田瑗 刘龙 王莹 崔兰.亚临床甲状腺功能减退症与冠心病及其危险因素的相关性研究[J].国际内分泌代谢杂志,2015,(05):298.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.003]
Tian Yuan*,Liu Long,Wang Ying,et al.Correlation of subclinical hypothyroidism with coronary heart disease and its risk factors[J].International Journal of Endocrinology and Metabolism,2015,(06):298.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.003]
[5]陈芬琴,王秋月.柚皮苷对糖尿病肾脏疾病的作用机制[J].国际内分泌代谢杂志,2017,37(04):239.
Chen Fenqin*,Wang Qiuyue..The mechanisms of naringin on diabetic kidney diseases[J].International Journal of Endocrinology and Metabolism,2017,37(06):239.
[6]刘宇,王秋月.microRNA-124与糖尿病肾脏疾病[J].国际内分泌代谢杂志,2017,37(04):246.
Liu Yu,Wang Qiuyue..microRNA-124 and diabetic kidney diseases[J].International Journal of Endocrinology and Metabolism,2017,37(06):246.
[7]邓雪凤,曹雪亭,杨萍,等.慢性低度炎性反应与糖尿病肾脏疾病的
相关性分析:一项大样本病例-对照研究[J].国际内分泌代谢杂志,2017,37(06):373.
Deng Xuefeng,Cao Xueting,Yang Ping,et al.Relationship between chronic low-grade inflammation and diabetic kidney disease: a large case-control study[J].International Journal of Endocrinology and Metabolism,2017,37(06):373.
[8]王隽书 杨光燃.亚临床甲状腺功能减退症动物模型的研究进展[J].国际内分泌代谢杂志,2018,38(04):247.[doi:10.3760/cma.j.issn.1673-4157.2018.04.007]
Wang Junshu,Yang Guangran..Recent progress of subclinical hypothyroidism animal models[J].International Journal of Endocrinology and Metabolism,2018,38(06):247.[doi:10.3760/cma.j.issn.1673-4157.2018.04.007]
[9]李扬 薛萌 胡芳 关美萍 薛耀明.Klotho在糖尿病肾脏疾病中的抗纤维化作用[J].国际内分泌代谢杂志,2018,38(01):48.[doi:10.3760/cma.j.issn.1673-4157.2018.01.013]
Li Yang,Xue Meng,Hu Fang,et al.Anti-fibrotic effects of Klotho in diabetic kidney disease[J].International Journal of Endocrinology and Metabolism,2018,38(06):48.[doi:10.3760/cma.j.issn.1673-4157.2018.01.013]
[10]徐瑶 王秋月.Akt/FoxOs信号通路与糖尿病肾脏疾病[J].国际内分泌代谢杂志,2018,38(02):117.[doi:10.3760/cma.j.issn.1673-4157.2018.02.012]
Xu Yao,Wang Qiuyue..Akt/FoxOs signal pathway and diabetic kidney disease[J].International Journal of Endocrinology and Metabolism,2018,38(06):117.[doi:10.3760/cma.j.issn.1673-4157.2018.02.012]